Skip to main content

Author: Customer Service

Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program

HALIFAX, Nova Scotia, July 03, 2026 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases today announced that it has received a Notice of Termination for Convenience from the National Institute of Allergy and Infectious Diseases (“NIAID”), part of the National Institutes of Health (“NIH”), in connection with the Company’s contract supporting development of the VXV-01 fungal vaccine candidate. The notice relates to contract number 75N93025C00033, which was awarded in October 2025. The five–year contract consists of a base period and twelve option periods, of which a 22-month base period of performance totalling US$3.6 million had been awarded. Appili is currently assessing the scope and potential implications...

Continue reading

Canfor completes acquisition of Calgary-based PinkWood Ltd.

VANCOUVER, British Columbia, July 03, 2026 (GLOBE NEWSWIRE) — Canfor Corporation (TSX: CFP) is pleased to announce it has completed the acquisition of PinkWood Ltd, Western Canada’s largest I-joist facility based in Calgary, Alberta. The acquisition, announced on June 9, 2026, complements Canfor’s existing operations in Alberta and British Columbia. “We’re excited to welcome the PinkWood operation, its management team and its employees to the Canfor family,” said Susan Yurkovich, President and CEO of Canfor. “The acquisition represents a strong strategic fit for both companies and supports the continued growth of Canfor’s value-added manufacturing capabilities.” PinkWood will retain its name and operate as a wholly owned subsidiary of Canfor. The operation will add 120 employees, and 46 million linear feet of annual I-joist production...

Continue reading

Court Approval of a Restructuring Transaction Allowing Continuation of Uninterrupted Operations

MONTREAL, July 03, 2026 (GLOBE NEWSWIRE) — PREMIER HEALTH OF AMERICA INC. (TSX-V: PHA) (“Premier Health” or the “Company”) announces that, in connection with the proceedings initiated on June 23, 2026 by the Royal Bank of Canada (the “Applicant”) in its capacity as a secured creditor (the “CCAA Proceedings”), the Québec Superior Court (Commercial Division) (the “Court”) has issued today an order approving the acquisition of all of the equity interests in three affiliates of the Company, namely Solutions Staffing Inc. (“SSI”), Canadian Health Care Agency Ltd. (“CHCA”) and Premier Soin Nordik Inc. / Premier Health Nordik Inc. (“Nordik Québec”), by way of reverse vesting orders (the “Transaction” and the “Approval and Reverse Vesting Orders”). Polar Valley Investments Limited (“Polar”), which owns a number of health care companies,...

Continue reading

Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West

VANCOUVER, British Columbia, July 03, 2026 (GLOBE NEWSWIRE) — Refined Energy Corp. (CSE: RUU; OTC: RRUUF; FRA: CWA0) (“Refined” or the “Company”) has received final analytical results for its maiden Winter 2026 drill program at Eagle Plains Resources (TSX-V:EPL) (OTCQB: EGPLF) (“EPL” or “Eagle Plains”) 100% owned Dufferin West Property, located in Saskatchewan’s Athabasca Basin uranium district. Refined holds the exclusive option to acquire up to a 75% interest in the project. The Dufferin Project consists of 10,140 hectares and is comprised of the North and West Dufferin. The 2026 drill program tested targets identified through the interpretation of electromagnetic, gravity and magnetic geophysical surveys. The 2026 drilling tested targets identified through interpretation of electromagnetic, gravity and magnetic geophysical surveys....

Continue reading

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08

NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective July 1, 2026, in connection with commencing employment as Head of Product of BetterHelp, David Packles was granted an award of restricted stock units covering 50,000 shares of Teladoc Health’s common stock, par value $0.001 per share (“Common Stock”). The restricted stock units vest, based on continued service to Teladoc Health, as to one-third of the underlying shares on the first anniversary of the grant date, with the remainder vesting quarterly over two years thereafter. The award was approved by the Compensation Committee of the Board of Directors of Teladoc Health and was granted under the Teladoc Health, Inc. 2023 Employment Inducement...

Continue reading

CREDIT AGRICOLE SA: Crédit Agricole now stands at 29.3% of Banco BPM’s share capital

Press release Montrouge, July 3, 2026 Crédit Agricole now stands at 29.3% of Banco BPM’s share capital Crédit Agricole S.A. (“Crédit Agricole”) has notified the Italian Authority and Banco BPM SpA (“Banco BPM”) that it has crossed the 25% threshold and currently stands at 29.3% of Banco BPM’s share capital. This additional stake has been accumulated through market purchases of shares and a derivative instrument. Crédit Agricole has a long-standing and deeply rooted presence in the Italian market and remains committed to supporting the Italian economy. The increase in ownership is consistent with Crédit Agricole’s strategy as a long-term investor and partner of Banco BPM in its development. This also further strengthens the solid industrial partnerships in consumer finance and in non-life, personal protection and creditor protection insurance,...

Continue reading

REE Automotive Announces Receipt of Nasdaq Delisting Notice

TEL AVIV, Israel, July 03, 2026 (GLOBE NEWSWIRE) — REE Automotive Ltd. (Nasdaq: REE) (“REE” or the “Company”), an automotive technology company that develops and builds software-defined vehicle technology, today announced that it has received a letter from The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that due to the fact that it  has not regained compliance with Nasdaq Listing Rule 5550(a)(2), the Nasdaq staff has determined to delist the Company’s Class A ordinary shares (the “Ordinary Shares”) from The Nasdaq Capital Market (the “Delisting Determination”) and its Ordinary Shares will be suspended from trading on the Nasdaq Capital Market on July 7, 2026. As previously reported, the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2), as the closing bid price for its Ordinary Shares was below $1.00...

Continue reading

Total number of shares and voting rights at June 30, 2026

3 July 2026 Orange: information on the total number of shares and voting rights referred to in Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers. In application of Article L. 22-10-46 of the French Commercial Code (Code de commerce), as from 3 April 2016, a double voting right is automatically granted to fully paid-up shares that have been held in registered form and under a single shareholder name for at least two years.Date Number of shares Number of treasury shares without voting rights Theoretical number of voting rights [1] Number of voting rights exercisable01/31/2026 2,660,056,599 1,457,248 3,180,394,670 3,178,937,42202/28/2026 2,660,056,599 1,756,848 3,181,578,829 3,179,821,98103/31/2026 2,660,056,599 1,756,848 3,179,834,278 3,178,077,43004/30/2026 2,660,056,599 773,640 3,182,170,153 3,181,396,51305/31/2026 2,660,056,599 590,180 3,182,009,609 3,181,419,42906/30/2026 2,660,056,599 2,287,263 3,175,694,720 3,173,407,457[1]...

Continue reading

IPSEN – Buy-back programme – Art 5 of MAR – Week 26- 2026

 Aggregated presentation by day and by marketPurchases of own shares from June 22nd to June 26th 2026             Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code)IPSEN 549300M6SGDPB4Z94P11 22/06/2026 FR0010259150 2 139 155.6891 XPARIPSEN 549300M6SGDPB4Z94P11 24/06/2026 FR0010259150 2 500 163.2722 XPARIPSEN 549300M6SGDPB4Z94P11 25/06/2026 FR0010259150 3 000 162.7671 XPARIPSEN 549300M6SGDPB4Z94P11 26/06/2026 FR0010259150 4 156 161.6177 XPAR      TOTAL 11 795 161.1856  AttachmentIPSEN – Buy-back programme – Art 5 of MAR – Week 26_2026

Continue reading

Planisware – Half-yearly report on the liquidity contract – H1 2026

Half-yearly report on the liquidity contract Under the liquidity contract entrusted by Planisware SA to Rothschild Martin Maurel, the following resources were included in the liquidity account as of June 30, 2026:2,000 shares € 1,713,481During the period from 01/01/2026 to 30/06/2026 the following transactions were executed:  Number of transactions executed Traded volumesin number of shares Traded volumesin €Buy 6,780 504,050 9,275,869.20Sell 5,950 502,050 9,146,930.14It is recalled that as of December 31, 2025, the following means were included in the liquidity account:0 shares € 1,825,400Following the reorganization within the Rothschild & Co group and the transfer of Rothschild & Co Martin Maurel’s market-making activities to Rothschild & Co Global Markets Solutions (Europe) SA, the latter has assumed...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.